<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on July 28, 2020</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03699228</url>
  </required_header>
  <id_info>
    <org_study_id>jst2018</org_study_id>
    <nct_id>NCT03699228</nct_id>
  </id_info>
  <brief_title>China Health Big Data</brief_title>
  <acronym>China biobank</acronym>
  <official_title>China Nationwide Multi Center Big Data Study on the Quantitative Computed Tomography (QCT) and Health Status of Check -up Population</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Beijing Jishuitan Hospital</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>Chinese PLA General Hospital</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Ruijin Hospital</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Huashan Hospital</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Henan Provincial People's Hospital</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>The Affiliated Hospital Of Guizhou Medical University</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>The First Affiliated Hospital of Zhengzhou University</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>First Affiliated Hospital Xi'an Jiaotong University</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>The renmin hospital of wuhan university</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Nanjing BenQ Hospital</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>China-Japan Friendship Hospital</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>xinan hospital</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Wu Hu Yijishan hospital</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>The fifth affiliated hospital of zhong shan university</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>Beijing Jishuitan Hospital</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      In this nationwide multi center study the investigators combine the low dose chest CT scan
      data with QCT technology, to measure the BMD of spine, VAT and liver fat in the health check
      subjects. The aim of this study is to evaluate the performance of QCT in the health check
      field, and further to evaluate the prevalence of osteoporosis, obesity and liver steatosis in
      health check population across China.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Low dose Chest CT scan is the standard for lung cancer in the health check center in China.
      Quantitative computed tomography (QCT) is utilizing the CT raw data to measure the bone
      mineral density (BMD), the visceral fat (VAT) and liver fat content in human, which can be
      widely used in the diagnosis of osteoporosis, the assessment of obesity and liver steatosis.
      In this nationwide multi center study the investigators combine the low dose chest CT scan
      data with QCT technology, to measure the BMD of spine, VAT and liver fat in the health check
      subjects. This study is to evaluate the performance of QCT in the health check field, and
      further to evaluate the prevalence of osteoporosis, obesity and liver steatosis in health
      check population across China.
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">December 1, 2017</start_date>
  <completion_date type="Anticipated">December 31, 2020</completion_date>
  <primary_completion_date type="Anticipated">June 30, 2020</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Other</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>The spinal volumetric bone mineral density (vBMD)</measure>
    <time_frame>2 year</time_frame>
    <description>The volumetric bone mineral density of L1-2 measured by QCT</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>The visceral adipose tissue (VAT)</measure>
    <time_frame>2 year</time_frame>
    <description>The visceral adipose tissue (VAT) measured by quantitative computed tomography (QCT)</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Liver fat</measure>
    <time_frame>2 years</time_frame>
    <description>Liver fat measurement by quantitative computed tomography (QCT)</description>
  </secondary_outcome>
  <enrollment type="Anticipated">30000</enrollment>
  <condition>Osteoporosis</condition>
  <condition>Obesity</condition>
  <condition>Liver Steatoses</condition>
  <eligibility>
    <study_pop>
      <textblock>
        General health check population
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:

        health check subjects 30-90 years old low dose chest CT scan

        Exclusion Criteria:

        pregnant women metal implant in the CT scan area
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>30 Years</minimum_age>
    <maximum_age>90 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>xiaoguang cheng, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Beijing Jishuitan Hospital</affiliation>
  </overall_official>
  <overall_official>
    <last_name>qiang zeng</last_name>
    <role>Principal Investigator</role>
    <affiliation>General PLA hospital</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>xiaoguang cheng, md</last_name>
    <phone>0086-010-58516947</phone>
    <email>xiao65@263.net</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>xiaoxia fu, md</last_name>
    <phone>0086-13683132746</phone>
  </overall_contact_backup>
  <location>
    <facility>
      <name>Wu Hu Yijishan Hospital</name>
      <address>
        <city>Wu Hu</city>
        <state>Anhui</state>
        <zip>100035</zip>
        <country>China</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>xiaojun zha</last_name>
      <phone>008613705533568</phone>
    </contact>
  </location>
  <location>
    <facility>
      <name>Beijing Jishuitan hospital</name>
      <address>
        <city>Beijing</city>
        <state>Beijing</state>
        <zip>100035</zip>
        <country>China</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Kai Li, PhD</last_name>
      <phone>008615801633664</phone>
    </contact>
    <investigator>
      <last_name>Ling Wang, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>The first affiliated hospital of Guiyang Medical University</name>
      <address>
        <city>Guiyang</city>
        <state>Guizhou</state>
        <country>China</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Xia Du, MD</last_name>
      <phone>008613765071289</phone>
    </contact>
  </location>
  <location>
    <facility>
      <name>The first affiliated hospital of Zhengzhou University</name>
      <address>
        <city>Zhengzhou</city>
        <state>Henan</state>
        <country>China</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Yan Wu, MD</last_name>
      <phone>008613803843588</phone>
    </contact>
  </location>
  <location>
    <facility>
      <name>Hua Shan hospital</name>
      <address>
        <city>Shanghai</city>
        <state>Shanghai</state>
        <country>China</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Shuang chen</last_name>
      <phone>008613601717952</phone>
    </contact>
  </location>
  <location>
    <facility>
      <name>Shanghai Ruijin hospital</name>
      <address>
        <city>Shanghai</city>
        <state>Shanghai</state>
        <country>China</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Yong Lu, MD</last_name>
      <phone>008613701995934</phone>
    </contact>
  </location>
  <location_countries>
    <country>China</country>
  </location_countries>
  <verification_date>January 2020</verification_date>
  <study_first_submitted>October 5, 2018</study_first_submitted>
  <study_first_submitted_qc>October 5, 2018</study_first_submitted_qc>
  <study_first_posted type="Actual">October 9, 2018</study_first_posted>
  <last_update_submitted>January 26, 2020</last_update_submitted>
  <last_update_submitted_qc>January 26, 2020</last_update_submitted_qc>
  <last_update_posted type="Actual">January 28, 2020</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Beijing Jishuitan Hospital</investigator_affiliation>
    <investigator_full_name>xiaoguang Cheng</investigator_full_name>
    <investigator_title>professor of radiology, chairman of department</investigator_title>
  </responsible_party>
  <keyword>Bone mineral density, quantitative computed tomography, Osteoporosis, obesity, liver steatosis</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Osteoporosis</mesh_term>
    <mesh_term>Fatty Liver</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

